Cataract surgery complications linked to BPH drug tamsulosin

Medication Used to Treat Urination Difficulties for Men Associated With Higher Risk of Ophthalmic Complications Following Cataract Surgery – Use of the medication tamsulosin to treat male urination difficulties within two weeks of cataract surgery is associated with an increased risk of serious postoperative ophthalmic adverse events such as retinal detachment or lost lens, according to a study in the May 20 issue of JAMA.

Cardiorespiratory fitness lowers heart disease risk

Better Cardiorespiratory Fitness Related to Lower Risk of Death, Cardiovascular Disease – Persons with higher levels of cardiorespiratory fitness have a lower risk of all-cause death and coronary heart disease and cardiovascular disease compared to persons with lower levels of cardiorespiratory fitness, according to an analysis of previous studies appearing in the May 20 issue of JAMA.

Substance abuse increases crime risk in schizophrenia patients

Substance Abuse Appears To Be an Important Factor in Increased Risk of Violent Crime By Persons With Schizophrenia – The increased risk of persons with schizophrenia committing violent crime may be largely mediated by co-existing substance abuse problems, according to a study in the May 20 issue of JAMA.

Bone marrow cell therapy for ischemic heart disease patients

Bone marrow cell therapy may be beneficial for patients with ischemic heart disease – The injection of bone marrow cells into the heart of patients with chronic myocardial ischemia (reduced blood flow to some areas of the heart) was associated with modest improvements in blood flow and function of the left ventricle, according to a study in the May 20 issue of JAMA.

Cognitive behavior therapy better for insomnia treatment

Combination Therapy Appears Helpful for Short-Term Treatment of Insomnia; Cognitive Behavior Therapy May Be Better for Long-Term – For patients with persistent insomnia, a combination of cognitive behavior therapy (CBT) and the medication zolpidem for 6 weeks was associated with modest improvement in sleep, although for a longer treatment period CBT alone was more beneficial, according to a study in the May 20 issue of JAMA.

Sleep aid increases CPAP adherence in sleep apnea patients

2-week course of sleep aid increases CPAP adherence in OSA patients at 6 months – New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent with therapy in six months.

Obese heart disease patients tend to live longer

Heart disease patients carrying extra pounds do better, live longer – Weight of evidence still points to purposeful weight loss, further research needed. – Being overweight or obese is a leading contributor to cardiovascular disease (CVD) and associated risk factors; however, in patients with established CVD, obesity appears to play a protective role.

Low income breast cancer patients skipping hormonal therapy

Low-income breast cancer patients skipping hormonal therapy, increasing their risks – Many low-income women are failing to take the hormonal therapy prescribed as part of their breast cancer treatment, possibly lowering their survival rates, according to a study led by a researcher in the Duke Comprehensive Cancer Center.

Sleep may be factor in weight control, BMI

Could sleep be a critical component to maintaining a healthy body weight? – Body mass index (BMI) is linked to length and quality of sleep in a surprisingly consistent fashion, revealed by researchers on Sunday, May 17, at the American Thoracic Society’s 105th International Conference in San Diego.

Cimzia in prefilled syringe for Crohn’s disease patients

Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn’s Disease – Cimzia (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor) for reducing signs and symptoms of Crohn’s disease is now available for self-administration in a prefilled syringe.

Risperdal Consta approved for bipolar disorder

FDA grants approval for use of RISPERDAL CONSTA as both a monotherapy and adjunctive therapy in the maintenance treatment of Bipolar I Disorder – Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL? CONSTA? (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.

GSK to manufacture A H1N1 influenza vaccine

GSK has received orders from several governments aiming to stockpile a new candidate A (H1N1) adjuvanted influenza vaccine as a precautionary measure – Company to manufacture the new vaccine, once virus seed is made available by the WHO. – GSK is committed to supporting governments and health authorities around the world to respond to the emergence of the new A (H1N1) influenza strain.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia